Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-14

Clinical Trial Update: Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial assessing gabapentin for pain control after osmotic dilator insertion and before dilation and evacuation (D&E).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: University of California, Davis | Conditions: Abortion, Induced, Cervical Preparation | Phase 4 | Status: COMPLETED | Results posted: 2020-04-14